ArticleBMJ open2022

cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study.

Dorothea Dehnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.